Introduction Depression is a major issue worldwide and is seen as a significant health problem. Stigma and patient denial, clinical experience, time limitations, and reliability of psychometrics are barriers to the clinical diagnoses of depression. Thus, the establishment of an automated system that could detect such abnormalities would assist medical experts in their decision-making process. This paper reviews existing methods for the automated detection of depression from brain structural magnetic resonance images (sMRI). Methods Relevant sources were identified from various databases and online sites using a combination of keywords and terms including depression, major depressive disorder, detection, classification, and MRI databases. Reference lists of chosen articles were further reviewed for associated publications.
Introduction
Depression is the most common mental disorder worldwide and currently the fourth largest contributor to the burden of disease as reported by the World Health Organization [1] . It is estimated that, by 2020, depression will remain a leading cause of disability, second only to cardiovascular disease [1] . Depression is a complex phenomenon with many subtypes and probably more than one etiology. It is a long-term recurrent disease in most people, with significant morbidity, mortality, and psychosocial impairment. Depression is associated with widely varying psychological and physiological features, and this heterogeneity is acknowledged within classification systems [2] .
A recent epidemiological study by Bromet et al. [3] indicated that approximately 121 million people worldwide have been affected by depression. Suicide is the worst consequence of depression, with up to 850,000 deaths reported every year [4] . Suicide rates have been shown to increase with age for both males and females: from 1 death per 100,000 young people aged 12 to 14 years to 5 deaths per 100,000 people aged 15 to 17 years and 13 deaths per 100,000 people aged 18 to 24 years [3] . Despite the efforts devoted to the recognition and treatment of depression, new data suggest that the prevalence of depression may be on the rise, in particular in younger people [5] .
The aim of this paper is to review the literature on the detection of depression from structural magnetic resonance images (sMRI) and describe the current methods available in automating the detection process. More specifically, the paper endeavors to (1) propose a generic structure for automated sMRI-based depression detection systems consisting of image acquisition and preprocessing, feature extraction, feature selection, and classification components, (2) investigate the existing depression detection approaches in the context of the proposed generic structure, (3) compare the performances of the depression detection systems, (4) identify the shortcomings of the reported works, and (5) recommend other brain imaging analysis methods that could be employed to enhance the performance, reliability, and accuracy of the existing works.
Symptoms and types of depression
Symptoms of depression include feelings of sadness and hopelessness, obvious loss of interest, anger, guilt, loneliness, chronic apathy, low energy level, and tendency to suicidal thoughts [6] [7] [8] [9] . Both biological and psychological factors are assumed to play a role in the development of depression [10] . Stress, anxiety, and some vitamin and mineral deficiencies have also been shown to be triggers of depression [11] . Depression is highly comorbid with other psychiatric illnesses and is frequently found to coexist with chronic medical conditions such as cardiovascular disease, multiple sclerosis, diabetes mellitus, arthritis, and cancer [12] [13] [14] [15] [16] [17] [18] . According to Aguirre et al. [6] , the main causes of depression are genetic factors, medical conditions, and environmental circumstances.
Depression types and descriptions are described in Table 1 . The most commonly diagnosed and arguably the most severe type of depression is major depressive disorder (MDD) [19] . The DSM-IV [2] includes four distinct depressive subtypes: melancholic, atypical, catatonic, and postpartum [8] . It has been reported that patients with MDD are up to 15 % more likely to commit suicide over the course of their lifetime [8] . The severity of MDD is typically divided into three classes: mild, moderate, and severe with or without psychotic features.
Clinical diagnosis of depression A diagnosis of depression is based on one's judgment to whether or not set symptomatic criteria are being met. Thus, the diagnosis procedures depend on the patient's understanding and cooperation as well as the investigator's skill in obtaining information [20] . The steps in diagnosing depression are illustrated in Fig. 1 (adopted from refs. [6, 8, 19] ).
First, a clinical history is gathered and verbal report (e.g., having a depressed mood and hearing voices) is acquired from the patient by the physician. Second, a standard physical examination is conducted, sometimes including laboratory tests (e.g., blood test), in an attempt to exclude organic causes [21] [22] [23] [24] . Referral to a specialist is often the next step. At this stage, further assessment is carried out and sometimes screening tests are given. Some widely used screening tests for the evaluation of depression include the Hamilton Rating Scale for Depression (HRSD) [25] , Diagnostic Interview Schedule [26] , and Hospital Anxiety and Depression Scale [27] . Furthermore, a mental status examination, being an assessment of the patient's level of cognitive ability, appearance, emotional mood, speech, and thought patterns at the time of evaluation, is routinely conducted [28] . Finally, following a positive screen of depression, tests such as the Montgomery-Asberg Depression Rating Scale [29] , Inventory of Depressive Symptomatology [30, 31] , and the Quick Inventory of Depressive Symptomatology [32] can be used to assess the severity of depression.
Treatment of depression
There is considerable evidence showing that depression can be effectively treated by pharmacotherapy and/or psychotherapy. Antidepressant therapies include selective serotonin reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, and selective noradrenaline reuptake inhibitors [8, sMRI as a potential diagnostic modality
Despite several biomarkers being shown to be associated with depression, to date, there are no specific medical tests that can objectively diagnose depression. In current practices, further tests are generally only requested to rule out the possibility that the symptoms of depression are being caused by other medical illnesses [24, 35] . Currently, a number of imaging methods are being investigated as potential diagnostic modalities for depression including positron emission computed tomography, sMRI, functional magnetic resonance imaging (fMRI), single-photon emission computed tomography, diffusion tensor imaging, and computed tomography. sMRI is a widely available [36] and widely used neuroimaging technique in research as well as clinical practice [37] . Structural brain imaging has the potential to influence the diagnosis of psychiatric disease [38] . It can demonstrate certain patterns of brain changes that may be present at a structural level [39] [40] [41] [42] [43] [44] [45] [46] [47] . sMRI using T1-weighted (T1-w) and T2-weighted (T2-w) contrasts has become an accepted standard for routine examination of the brain [37] . For example, sMRI diagnostic modality has been integrated in the clinical assessment of neurodegenerative disease [48, 49] . According to Lorenzetti et al. [47] , T1-w sMRI in comparison with other MRI modalities including fMRI or even magnetic resonance spectroscopy provides a more stable brain measure that minimizes state-related processes relating to the stage of illness, recovery, and outcome. Steffens and Krishnan [50] describe that the use of functional imaging will not replace structural imaging research. In a recent publication, Zeng et al. [51] stated that neuroimaging evidence, such as structural abnormality other than resting state functional connectivity, is needed as a synthesized biomarker for more reliable clinical diagnosis of this complex disorder.
The standard clinical workup for many developmental neuropsychiatric disorders already includes an sMRI scan of the brain [52] . Research to date has shown that depression can be linked to specific structural brain regions abnormalities [53] [54] [55] [56] [57] [58] . sMRI offers anatomical detail and high sensitivity to pathological changes [37] . The performance of sMRI as a depression diagnostic tool is comparable to certain modalities and superior to other modalities [59] [60] [61] [62] [63] [64] [65] . Compared to most imaging modalities, sMRI has a superior soft tissue contrast [66] , the highest spatial resolution, and unlimited repeated measurements and is noninvasive [67] . Numerous classification studies that used sMRI in psychiatric disorder have demonstrated promising results, suggesting the potential of sMRI as a diagnostic tool in diseases such as bipolar disorder, schizophrenia, psychosis, and depression [68, 69] .
Compared to fMRI, sMRI has more advantages, with scans being easier, quicker, and cheaper to obtain [70] . Besides, fMRI gives rise to complexities associated with the choice and design of the behavioral paradigm; it needs an understanding and cooperation of subjects with the task [70] . Moreover, the acquisition of task-related data becomes increasingly difficult in many pediatric and clinical populations due to differing abilities in performing the required task [52] . Therefore, it is likely that resting-state fMRI may be more practical in more severely impaired patients.
sMRI acceptance in clinical research and practice demonstrate its potential and usability in clinical diagnostics. The application of sMRI in depression diagnostic will be increased by standardization of acquisition and analysis methods and development of robust algorithms and features. sMRI depression biomarkers Biomarkers refer to specific features of an individual that are useful in distinguishing the presence or absence of a disease state ("diagnostic biomarkers") or predict treatment response ("treatment biomarkers") [58, 71] . A biomarker is defined as a characteristic that can be objectively measured and evaluated as an indicator of normal or abnormal biological processes or as an indicator of pharmacological responses to a therapeutic intervention [72] . Generally, biomarkers are used as a diagnostic tool for the identification of those patients with a disease or abnormal condition, as an Other Tests: rating scales and possibly brain imaging scans and blood tests (to exclude the possibility due to a medical condition) Fig. 1 General procedure for the clinical diagnosis of depression indicator of disease prognosis, as a tool for staging of disease, and as a tool for predicting and monitoring of clinical response to an intervention [72] . Volumetric reductions or increase in the hippocampus, amygdala, anterior cingulate cortex (ACC), orbitofrontal cortex (OFC), dorsolateral prefrontal cortex, subgenual prefrontal cortex (SGPFC), putamen, caudate, and also cerebrospinal fluid (CSF) have been specifically associated with depression [73] [74] [75] .
Previous studies have shown a morphometric reduction of the hippocampus (bilateral hippocampus, left and right hippocampus, and hippocampus gray matter [GM]) in patients with MDD compared to healthy controls [39, 71] . The bilateral reduction in hippocampal volume has been shown to be about −5 % [73, 76] , whereas Schneider et al. [71] , who also found volume reductions of the hippocampus, reported left hippocampal volume reductions in MDD of −8 and −10 % in the right hemisphere when compared with healthy controls. The Q test of heterogeneity in ref. [46] showed highly significant result (left side: p<0.003 and right side: p<0.01).
Amygdala volume increases in the early stages of MDD in comparison to controls have been reported [71] . There is also evidence suggesting that amygdala volume decreases significantly with increasing number of depressive episodes and longer illness duration [56, 71, 77] .
Analyses of the frontal cortex have shown large volume reductions in the ACC and OFC, with smaller reductions in the prefrontal cortex [47, 71] . Meta-analysis by Arnone et al. [39] and Kempton et al. [76] tested the presence of heterogeneity using the Cochran Q test. The volume of the total frontal cortex was found to be significantly reduced in patients with MDD in comparison with healthy controls with a trend to moderate heterogeneity (p=0.079) [39] . The analysis of the left OFC showed significant evidence of moderate heterogeneity (p=0.021), with GM but not white matter (WM) contributing to the volume reduction in the OFC bilaterally [39] . In regards to the ACC, evidence exists suggesting that the volume of the right ACC is reduced in patients with MDD compared to healthy controls without significant heterogeneity (p=0.15), whereas no differences have been shown for the analyses in the left cingulate cortex and SGPFC [39] . Although larger effect sizes were evident for the left SGPFC with increasing illness severity (p=0.001), a fraction of patients treated with antidepressants (p=0.001) or with antipsychotics and mood stabilizers (p=0.001) had a smaller effect size with progressive fraction of time elapsed since diagnosis (p=0.009) [39] .
Previous studies analyzing the caudate indicate a significant volume reduction in the presence of MDD with marginal evidence of moderate heterogeneity (p=0.08) [39] . This reduction was found not to be significant in the left and right caudate when data were analyzed separately [39, 71] . Similarly, the putamen showed significant volume reduction (p=0.38) [39] . In the left and right putamen, the reduction did not reach a level of significance, but there was statistically significant evidence of moderate heterogeneity (left: p=0.034 and right: p=0.02) [39, 71] . Compared with healthy controls, the volume of the pituitary gland was also shown to be increased in depression patients (p=0.059) [39] , with 5 % increment (p=0.054) [76] . There was also evidence for an excess of WM lesions in depression (p= 0.082) and those of older age (p=0.028) [39] . Analysis of the CSF only showed a trend towards a volume increase in depression [39, 76] , with significant and moderate heterogeneity (p=0.006) [39] .
sMRI data analysis
There are two fundamental approaches of sMRI data analysis. The first and more frequently implemented type is known as group-level analysis studies. Group-level analysis compares groups of patients with depression to healthy controls focusing on detecting average group-level differences. The disadvantage of these group-level studies is that the results cannot be applied to the diagnosis of individual patients. The second type of analysis aims to detect or classify individual patients. We hereafter refer to this type as individual detection, which is potentially clinically applicable [78] .
Group-level analysis
Group-level analysis is normally performed using conventional univariate approaches that analyze only one location at a time [79] and incorporates the following components: (1) acquisition and preprocessing, (2) segmentation of brain regions, (3) feature extraction, and (4) statistical significance test. Most of the previous studies in depression diagnosis research belong to the group-level analysis class [38, 43, [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] .
The majority of the group-level analysis methods [38, 43, [80] [81] [82] [83] [84] [85] use voxel-based morphometric (VBM) values aided by a statistical parametric map [94] [95] [96] [97] . In traditional volume comparison, the volume is measured by calculating the volume within the segmented regions of interest (ROIs). This calculation is time-consuming and only practical for large areas (whole brain), thus differences in the volume may be overlooked [98] [99] [100] . When using VBM, on the other hand, the image volume is compared across the brain at every voxel with chronological approaches [97] including (1) spatial normalization of the MR images into a standard template in stereotactic space (i.e., Montreal Neurological Institute (MNI) space [101] ) is carried out, (2) segmentation of the WM and the GM is performed by incorporating an image intensity nonuniformity correction, (3) spatial smoothing using isotropic Gaussian kernel convolution is implemented where the Gaussian kernel size of 4 to 12 mm full-width at half-maximum (FWHM) is used, (4) correction for volume change (applying a Jacobian determinant) is performed, and (5) voxel-wise statistical analysis that employs the general linear model and the differences in the brain are shown as patches of colors on an MRI brain slice. These values are then transformed to the normal distribution. The significance of each region is estimated by the distributional approximations from the theory of Gaussian random fields [102] . Although VBM is widely used in group-level statistical analysis, the application toward individual detection has now been made known as single-subject VBM [103] . It is worth stating that many of the published works in the group-level analysis are limited due to small sample sizes and insufficient data to support the reported findings [39, [104] [105] [106] .
Individual detection
The individual depression detection methods aim to classify whether an individual belongs to the depressed or the healthy group using pattern analysis methods that allow exploration of multivariate brain data. The shift of focus away from the group-level analysis methods towards the pattern analysis at individual level can shed light on the most suitable methods by which relevant information can be extracted from the brain sMRI scans [79] . To date, there are several individual depression detection studies based on sMRI [70, [107] [108] [109] [110] [111] . The components of the individual detection methods are similar to those of the group-level analysis methods, but more emphasis is given to feature selection and classification.
The published works on individual depression detection have used sMRI in differing ways. Costafreda et al. [107] pointed out the prognostic potential of sMRI. On the other hand, Nouretdinov et al. [108] highlighted the potential of transductive conformal predictors (TCP) for the classification of sMRI data for diagnostic and prognostic prediction in depression. Bao et al. [111] demonstrated the potential of using brain shape measurement for the prediction of remitted and nonremitted MDD. Gong et al. [109] indicated the importance of GM and WM in the diagnosis and prognosis of pretreatment MDD. Mwangi et al. [70] developed a hybrid method which combined support vector machines (SVM)/relevance vector machine (RVM) with feature selection (VBM) and feature description (feature-based morphometry [FBM]). They also showed that SVM and RVM weighting factors are correlated strongly with the subjective ratings of illness severity. In a different study, Mwangi et al. [110] proposed a model for the prediction of MDD illness severity scores using T1-w sMRI scans. This study [110] demonstrated that T1-w MRI scans contain sufficient information about neurobiological change in patients with MDD to permit accurate prediction on illness severity at an individual level, especially for the very ill patients.
Generic structure of sMRI-based depression detection
While the use of brain abnormalities as diagnostic criteria has been achieved and significant sMRI biomarkers of depression have been identified, the influence of the sMRIbased depression findings on clinical practice is very limited. There have been little efforts to formulate a reliable system that could automatically detect depression for clinical applications. On the other hand, many published studies exist that have described methods developed for automated and semiautomated brain MRI analysis. Therefore, we propose a generic structure for a system that can detect depression from sMRI. This structure is devised from the existing depression detection works reported in the literature. An ideal depression detection system should be able to detect whether an individual is depressed or not from the associated sMRI data, along with providing the severity of the condition.
Evaluation of sMRI of the brain is usually achieved through visual ratings performed by medical experts (i.e., radiologists, neuroradiologists). However, conventional evaluation of these scans often relies on manual reorientation, visual reading, and semiquantitative analysis of certain regions of the brain. These steps are difficult, timeconsuming, subjective, and prone to error [70] . In practice, no clinical expert would diagnose brain diseases only by looking at the abnormality of a single region of the brain [112] . Instead, clinical experts carry out a comprehensive visual inspection of every part of the brain. Therefore, an automated system is warranted.
Various tools have been developed to analyze brain sMRI data. Majority of the studies to date investigating depression have employed the following tools: SPM [113] , MRX [114] , GRID [115] , BRAINS [116] , Analyze [117] [123, 124] , Insight Toolkit (ITK) [45] , Automated Functional NeuroImaging (AFNI) [45] , MEDx [125] , Automated Image Registration (AIR) [126] , and Wake Forest University (WFU) PickAtlas Toolbox [83] . A review of the tools utilized in depression research reveal that VBM by SPM is the most popular and widely used tool for whole-brain analysis, whereas semiautomated tools, i.e., BRAINS and Analyze, are popular for specific brain regions segmentation and traditional volume measurement [127] . The proposed structure is displayed in Fig. 2 . It consists of a number of components including acquisition and preprocessing, feature extraction, feature selection, and classification. Some existing depression detection works include all these components, while others employ only some of the components. In the following section, each component is first defined, and then the existing methods relating to each component are described.
Image acquisition and preprocessing
Image acquisition is the process of acquiring medical images from imaging modalities. MRI scanners which have been used in the existing studies include 1.5-or 3.0-T magnetic strength machine (i.e., 1.5-T (Signa, General Electric, Milwaukee, WI, USA), 3.0-T (Trio, Siemens Medical Systems), 1.5-T (Magnetom Vision, Siemens, Erlangen, Germany), and 1.5-T GE LX System (General Electric, Milwaukee, WI, USA). In the published works, different MRI protocols used include T1-w, T2-w, PDweighted (PD-w), and fluid-attenuated inversion recovery (FLAIR) images (see Fig. 3 ). Brain MRI data can be found in public and private databases. According to the literature, most of the published works employed private databases that were constructed from recruited patients by partner hospitals or clinics. For depression sMRI data, the only publicly available databases thus far are the ELUDE (281 depressed, 154 controls) and MIRIAD (50 depressed, 50 controls) databases by the Neuropsychiatric Imaging Research Laboratory group from Duke University [129] .
Image preprocessing refers to the process of improving the quality and interpretability of the acquired brain images. Some of the preprocessing operations include nonuniformity intensity correction, noise reduction, realignment, transformation, registration, smoothing, normalization, and segmentation.
Some of the preprocessing techniques commonly used are realignment using performed initial alignment to the same orientation with the anterior commissure-posterior commissure alignment routine using a rigid body transformation [94] and smoothing by convolution with Gaussian kernel sized between 4 and 12 mm [83, 130, 131] . Tae et al. [81] implemented registration by maximum likelihood, while Ballmaier et al. [132] transformed brain image volumes into standard International Consortium for Brain Mapping 305 space using a 12-parameter linear, fully automated image registration algorithm. In the normalization process, all images are normalized to a standard size, orientation, and position typically in MNI space or Talairach coordinates [41, 125, 133] .
Segmentation of brain images refers to the process of delineating the neuroanatomical structures. The segmentation is usually performed in two stages: (1) brain tissue extraction and (2) brain ROI isolation. Brain tissue extraction is the process of removing the nonbrain tissues, such as skull and fat, and leaving only the brain tissue. It is reasonable to remove the nonbrain tissues to reduce computation time and increase efficiency. Brain ROI isolation is the process of segmenting the region of brain that is useful for the feature extraction process.
The techniques used for brain ROI isolation can be categorized into two groups: (1) tissue classification and (2) template registration. Many brain segmentation techniques exist, although only some have been utilized in depression research.
For brain tissue extraction, techniques implemented include brain masking [132] , tissue probability maps [81] , and deformable model [134] . After the brain tissue is extracted, the brain images are ready for brain ROI isolation. The brain images are typically segmented into the brain intracranial structures: GM, WM, and CSF or specific ROIs in GM/WM. Figure 4 illustrates sample segmented brain images of depressed subjects.
Among the segmentation techniques employed are Bayesian algorithm and spatial segmentation for wholebrain segmentation [81] , labeling techniques [135] , fourchannel tissue and lesion segmentation for WM detection [87] , histogram-based EM segmentation algorithm [136] , [128] signal intensity histogram distributions [137, 138] , stereologic sampling program using histogram segmentation [139] , unified segmentation [62, 83, 96] , k means [140] , and hidden Markov random field model with an associated EM algorithm [141, 142] .
For specific ROIs such as the hippocampus, amygdala, and ACC, these structures are generally outlined either by manual or semiautomated methods. The delineation process normally uses a mouse-driven cursor on semiautomated protocols by qualified raters. Manually traced ROIs including the hippocampus [89, 91, 124, [143] [144] [145] [146] [147] [148] , amygdala [45, 89, 91, 140, 144, 147, 149] , ACC [150] , and pituitary [141, 142] have been published. Most of the tracing works were performed on the coronal plane for best visualization.
Some of the segmentation protocols implemented in the reported works for the ROIs are Otsu's method [151] , semiautomatic model-based nonlinear segmentation method [152] , and semiautomated method that classify different tissues using the multiple MR signal contacts, which were employed by Taylor et al. [153] [154] [155] [156] [157] , Pan et al. [158] , Greenberg et al. [159] , Hannestad [88] , Potter et al. [160] , Chen et al. [86] , Bae et al. [161] , Steffens et al. [115, 162, 163] , Lee et al. [164] , Rosso et al. [89] , and Lai et al. [165] . This method was formed by Payne et al. [166] based on the segmentation protocols developed by Kikinis et al. [114] .
van Eijndhoven et al. [123] applied a semiautomated segmentation algorithm to segment the amygdala and the hippocampus using identification of anatomical boundaries with greater accuracies than a singular plane. For the BG segmentation, Posener et al. [148] applied a marching cube algorithm to make polygons to superimpose manually segmented data onto the surface in the template. Bergouignan et al. [80] performed automated segmentation of the hippocampus using the SACHA methods. The method requires the operator to define a bounding box and two seeds, one in hippocampus and one in amygdala. The algorithm aggregates voxels and converges to the segmentation of the two structures.
Feature extraction and selection
Feature extraction refers to the process of transforming the raw input data into a set of features with a reduced representation. The types of features employed so far in the depression detection from sMRI are the voxel intensity values, shape analysis results, traditional volume measurement, and VBM and lesions hyperintensities.
Voxel intensity values represent the gray-level values in the three-dimensional space. Voxel intensity values of the whole brain were used by Costafreda et al. [107] , Gong et al. [80] . c Left and right amygdala on coronal view by manual tracing [122] . d Left and right caudate and putamen on coronal view by manual segmentation using Analyze [171] [109], and Nouretdinov et al. [108] as the features, while Lee et al. [164] used signal hyperintensities and lesions of GM and WM as the features.
Volumetric analysis is the measurement of the volume of the selected brain regions. It is carried out by summing all voxels within the traced ROIs. For example, the hippocampus volume in the scanning space was measured by multiplying the number of voxels of the hippocampal mask by the size of the voxel of the image. Soriano-Mas et al. [85] , Egger et al. [84] , Steffens et al. [167] , Greicius et al. [168] , Taylor et al. [153] , and Bell-McGinty et al. [169] used the standard volume measurement of the whole brain or ROIs as the classification features. This traditional volume measure was normally used after manual or semiautomated segmentation (i.e., Hviid et al. [ [54] , and Mwangi et al. [70, 110] employed the VBM technique for feature extraction [94, 95] . The VBM method performs region-wise volumetric comparison among the group subjects.
Shape analysis is the measurement of geometrical properties at the anatomical features related to folds in the surface of the brain such as sulci, fundi, and pits. The measurement includes the cortical thickness, curvature, and depth. Shape analysis [171] has demonstrated a greater sensitivity than the volumetric features in detecting subtle anatomical differences in the small brain structures. Because changes in striatal shape may occur without detectable changes in overall volume, and vice versa, shape analysis can provide a complementary approach to the volumetric methods [171] .
Bao et al. [111] employed shape analysis for individual depression detection by using the fundus length, curvature, convexity, cortical measure, and depth for each point of sulci using the Mindboogle algorithms. Penttilä et al. [93] used graph-based representation for the shape analysis of cortical folding pattern in the sulcus areas. Graph-based representation includes the information related to morphology (area, depth, and length). The global sulcal index for each hemisphere was measured automatically as the ratio between the total sulcal area and the outer cortex area.
For multiple subjects comparisons, Zhao et al. [90] implemented a spherical harmonic (SPHARM) shape analysis technique to compare shape differences of the ROIs between depressed and healthy controls. The SPHARM algorithm used in their study has been described in detail elsewhere [172, 173] . Priebe et al. [174] and Qiu et al. [175] also used the structural shape of a population to avoid a statistical bias and failure of the mapping due to wide variation of the anatomy across subjects. For size and shape measurements of the corpus callosum, Walterfang et al. [151] proposed an iterative search for optimum end points that maximized the length of a line segment traversing the center of the callosum and were joined by a smooth curve via cubic spline interpolation, where the callosum length was measured.
Large deformation diffeomorphic metric mapping (LDDMM) was used by Qiu et al. [175] to generate the hippocampus shape of each subject and to characterize the surface deformation of each hippocampus relative to the template. The LDDMM aims to quantify metric distances on anatomical structures in medical images. Such deformation was modeled as a random field characterized by the LaplaceBeltrami basis functions in the template coordinates.
Tamburo et al. [45] implemented shape morphometry of the amygdala. The method of shape morphometry relies on generating parametric surface meshes for each segmented structure, calculating the distance from each surface point to the medial manifold, and comparing intergroup distance measures at each corresponding surface point. The resulting group differences are then translated into statistical maps.
Ballmaier et al. [132] utilized a surface rendering or surface warping algorithm, a high-resolution shape representation of the cortex that creates a spherical mesh surface that is continuously deformed to fit a cortical surface threshold intensity value. Priebe et al. [174] implemented shape-space analysis on the hippocampus structure of clinically depressed, highrisk, and control populations. A mapping model that reasonably measures accurate shape differences between two given hippocampus is constructed rather than an absolute value for shape itself. A nonparametric landmark matching transformation was implemented which finds the energy of a minimizing diffeomorphism (isomorphism of smooth manifolds) which includes both landmark mismatch and transformation complexity. Ballmaier et al. [132] used the brain size and the GM differences in their analysis. The brain size is the distance from center measure that is the radial distance of the cortex measured from the center of the brain.
Mwangi et al. [70] proposed an additional step known as feature description. They investigated a method known as FBM. In the FBM process, the GM voxel probabilities that were calculated through the DARTEL method are transformed into a gradient of local GM probability with the anatomical orientations of the gradients. The FBM method is a combination of "3D Scale Invariant Feature Transform" descriptor and the "Bag of Words" method.
Feature selection identifies the most useful features and reduces the dimensionality in such a way that the most significant aspects of the data are represented by the selected features [176] . Feature selection can be summarized into three categories: filter, wrapper, and hybrid methods [177] . The filter methods select variables by ranking them using correlation coefficients. The wrapper methods assess subsets of variables according to their usefulness to a given predictor [70] . The hybrid methods are similar to the wrapper methods but integrate optimization into the process [178] . A complete review of feature selection was published by Guyon and Elisseeff [177] .
Specifically, in depression, there are only few studies that reported on the feature selection process. Costafreda et al. [107] implemented the whole-brain analysis of variance filtering to select the areas of maximum group differences between patients and controls. Mwangi et al. [70] implemented a feature selection t test filter in VBM to identify the voxels that differed most in MDD patients vs healthy controls. They also investigated a wrapper feature selection method called recursive feature elimination.
Classification
Classification refers to the process of determining the class to which a sample belongs (i.e., depressed/not depressed, remitted/not-remitted depression) based on the values of the features of the sample.
Only a very few studies have been reported on the individual classification based on sMRI [70, [107] [108] [109] [110] [111] . These studies have demonstrated the use of machine learning algorithms as distinct classifiers for detecting depression. The SVM classifier was employed by Costafreda et al. [107] , Gong et al. [109] , and Bao et al. [111] . Besides the SVM classifier, Bao et al. [111] also investigated the k-nearest neighbor classifier for predicting treatment remission in MDD. Nouretdinov et al. [108] proposed a general probabilistic (GP) classification method to sMRI and fMRI to investigate diagnostic and prognostic prediction in depression. The proposed method of classification is known as TCP. Mwangi et al. [110] used regression analysis based on relevance vector regression (RVR) which is a sparse Bayesian leaning method to predict brain disease. In another published study, Mwangi et al. [70] investigated both RVM and SVM learning for diagnostic purpose.
Performance evaluation measures
Performance evaluation measures that have been used to evaluate the methods proposed for segmentation or classification of the brain MR images of depressed and healthy controls include sensitivity [107] , specificity [107] , and accuracy [107] [108] [109] . The three terms are defined as follows:
Sensitivity (also known as true positive fraction) is the probability that a diagnostic test is positive, given that the person has the disease:
Specificity (also known as true negative fraction) is the probability that a diagnostic test is negative, given that the person does not have the disease:
Accuracy is the probability that a diagnostic test is correctly performed:
where TPs (true positives) are correctly classified positive cases, TNs (true negatives) are correctly classified negative cases, FPs (false positives) are incorrectly classified negative cases, and FNs (false negatives) are incorrectly classified positive cases.
Other evaluation measures used in the literature to evaluate the classification performance include the receiver operating characteristic (ROC) and the area under the curve (AUC) [70] , F measure [70, 109] , Pearson correlation coefficient [110] , mean absolute error (MAE) [110] and root mean square error [110] . The descriptions of these measures are as follows:
ROC plots sensitivities along the vertical axis and 1− specificity along the horizontal axis. A random classification should yield a 45°line from the bottom left to the upper right with an AUC of 0.5. A system that is better than random should have its ROC above the 45°l ine with an AUC >0.5. F measure is a harmonic mean of precision and recall and defined as:
Precision and recall are then defined as:
Pearson correlation coefficient (r) measures the strength of the association between two variables/groups. r will always be between −1.0 and +1.0. There exist many forms of formula for r, where the commonly used formula is:
where N is the number pairs of scores, ∑xy sum of products or paired scores, ∑x sum of x scores, ∑y sum of y scores, ∑x 2 sum of squared x scores, and ∑y 2 sum of squared y scores.
MAE is given by:
whereas RMSE is defined as:
where t is the true value in the dataset and y is the predicted value estimated by the model.
Discussions and recommendations
Early detection of depression is key to better prognosis and appropriate treatment. There are still concerns that depression is poorly detected and that reliable severity measures are needed [64, 179] . The efficiency of antidepressants is largely based on trial, and individuals can take weeks to respond, if at all. Previous research has shown that approximately 33-41 % of those who committed suicide had contacted mental health services in the year prior to their death and 20 % within the month prior to their death [3] . Thus, more effective ways of detecting depression would more than likely reduce time to intervention and suicidal behavior.
Comparison of sMRI-based depression detection systems
The development of a depression detection system would provide an objective measure of depression, thus assisting in making conclusive decisions. The system output could serve as a second opinion, thus improving the confidence level of diagnosis. Our review of the existing sMRI-based depression detection methods reveals that the main bottleneck in comparing the results of the published works include (1) the difference in the delineated brain regions, (2) lack of clear boundaries between the preprocessing and segmentation process, and (3) lack of reporting of property settings of the used methods. Table 2 gives a comparison of the individual depression detection systems in terms of their performances. For the data used, we have included MRI magnetic strength, slice thickness, and intensity types from the published works wherever given. For the image acquisition, preprocessing, and segmentation methods, we have included information of the techniques implemented in the published studies wherever described. For the performance results, we have included significant test results, sensitivity, specificity, accuracy, and other measures from the published works wherever reported.
Investigation of the diagnosis potential of the sMRI by Costafreda et al. [107] produced diagnosis accuracy of 67.6 %, while Gong et al. [109] achieved accuracy ranging from 58.7 to 84.7 %. They found that the detection performance accuracy is influenced by the selection of ROIs (i.e., GM/WM) and the depression types. Investigation of the prognostic potential of the sMRI by Nouretdinov et al. [108] produced prognostic accuracy of 77.8 % [108] , Costafreda et al. [107] achieved accuracy of 88.9 %, and Bao et al. reported an F 1 score of 0.75 [111] . Mwangi et al. [70] achieved high prediction when combining VBM, FBM, and RVM, with an accuracy of 90 %, a sensitivity of 93 %, and a specificity of 87 %, and also when combining VBM, FBM, and SVM, with an accuracy of 85 %, a sensitivity of 84 %, and a specificity of 85 %. A study involving different methodologies by Mwangi et al. [110] applied a regression technique, RVR, for the prediction of the rating-scale scores from T1-w MRI scans. The RVR prediction correlation using the rating-scale score was high with Beck Depression Inventory (BDI) (r=0.694; p<0.0001) but low with HRSD (r=0.34; p=0.068).
Although the available research on sMRI for depression detection is still limited, sMRI depression diagnosis can be made with a high accuracy of around 90 % [70] . The most important improvement concerns the methods used to implement different components of the system. The performance results highlighted the potential of sMRI, although the small sample sizes and number of studies limit the ability to draw firm conclusions. Thus, replication studies are necessary in order to strengthen the available findings.
Image acquisition and preprocessing
From Table 2 , T1-w is the preferred imaging contrast for depression diagnosis. For image preprocessing, it is evident that, for most WB segmentation, fully automated methods (i.e., unified segmentation, mask labeling) which are mainly included in VBM are employed. However, for specific or smaller brain regions (i.e., putamen, hippocampus, amygdala), regions are generally manually traced using semiautomated methods (i.e., region growing, seeding). Manual segmentation is time-consuming and not practical for large sMRI studies [180] ; however, limited methods are available for fully automated segmentation of these specific/small regions. Our investigation of the available fully automated techniques for these specific/small regions have revealed a number of developed methods. Some examples of the published methods are hybrid segmentation that uses the knowledge derived from probabilistic atlases and anatomical landmarks [98] , fast marching for automated segmentation of the hippocampus using the Sethian fast marching to grow RVM relevance vector machine a hippocampal ROI from an automatically defined seed point [181] , a probabilistic-based FreeSurfer method combining with the LDDMM-based label propagation method [182] , and a patch-based method using expert manual segmentations as priors [183] . Most of these studies were validated using Alzheimer's disease MRI datasets. There are also a variety of MRI segmentation methods based on different brain diseases have been previously described [184] . Mortazavi et al. [184] proposed four main categories, based on the pattern recognition literature to cover the existing segmentation methods: (1) data-driven, (2) statistical, (3) intelligent, and (4) deformable models. Group-level investigations [38, 80, 81] have indicated that the chosen techniques for each component, properties setting, and ROIs delineation protocols have critical effects toward the accuracy of segmentation. Although T1-w has been the preferred type of sMRI in depression studies, there are a number of special cases, e.g., diagnosis of depression in specific ROIs such as white matter hyperintensities (WMH) where T2-w images can be employed. WMHs are areas of increased signal intensity that become apparent, particularly on T2-w sMRI [185] . Future depression research should attempt to employ fully automated segmentation methods particularly for the hippocampus and amygdala.
Feature extraction/selection
The extraction and selection of right features have considerable impact on the success or failure of the classification process. The review of the features used in the existing works is presented in Table 2 . It can be seen from the table that the existing classification methods employed a limited feature set, with the voxel density/values as the most common features. GM, WM, or WB voxel density/values have been used in studies by Costafreda et al. [107] , Gong et al. [109] , Mwangi et al. [70, 110] , and Nouretdinov et al. [108] . Beyond VBM analysis, recent research by Bao et al. [111] has focused on extracting more meaningful information from the shape of brain structures. They included features extracted from shape analysis such as fundus length, curvature, convexity, cortical thickness, and depth of sulcus to predict treatment response in MDD. This study highlighted the potential use of shape analysis for improving the detection accuracy [111] . For detection at the individual level, future work should investigate other features apart from the WB/GM/WM voxel density/values as discriminant features for investigation of the performance of sMRI diagnosis potential. If the WB voxel value/intensity is still to be employed, it is suggested that other features such as the mean, variance, skewness, and kurtosis of the image intensities can be extracted and investigated. These features have been previously demonstrated to have good potential in other brain disorder studies [186] .
There are many other features that can be extracted from sMRI data. The group-level analysis studies managed to detect the depressed group from the controls using more distinct features such as those extracted from specific pathological brain regions (i.e., amygdala, ACC, hippocampus, BG). Volume of the hippocampus/amygdala/ACC has been previously used to distinguish between depressed and healthy groups but not in the detection of individual depression. One possible reason for not implementing these features is the difficulty of segmenting the brain regions.
Another possible feature is the WM hyperintensities/lesions. El-Dahshan et al. [187] carried out classification using pathological brain tissues (e.g., lesions, tumors). The hyperintensities shown on the MRI are believed to indicate tissue abnormalities or lesions that have shown good distinction between depressed and healthy controls, particularly in geriatric depression [166, 185] . From the segmented pathological tissues, features such as volume, shape measure, texture, and intensity could be extracted. Besides, deformation-based features obtained from the deformation vectors computed by nonlinear registration processes as used by Savio et al. [188] can be also applied.
To integrate various features, an accurate dimensionality reduction approach can be employed to minimize the loss of relevant information for classification. It is expected that the information relevant for classification is well-preserved, thereby improving the classification accuracy. The reported studies on the investigation of feature selection from sMRI depression data used analysis of variance (ANOVA) [92] and VBM [70] . VBM limitation for feature selection is its direct discriminate voxels with individually low discriminative power. These low discriminative power voxels, when taken in conjunction with other voxels, may have significant combined power. In other imaging studies, principal component analysis (PCA) was employed by Fu et al. [63] and Marquand et al. [189] for feature selection. PCA is appealing because it reduces the dimensionality of the data and, therefore, reduces the computational cost of analyzing new data. However, Mwangi et al. [110] avoided dimensionality reduction techniques such as PCA. They used RVR that is a sparse algorithm that employs only a fraction of its basis functions to make predictions. A study by Chyzhyk et al. [190] employed lattice independent component analysis and the kernel transformation hybrid with dendritic computing classifiers. Other options include the use of multivariate approaches such as Gaussian mixture model and partial least square that can relieve the small sample size problem and extract feature vectors from the computation of the activation of each ROI in the image De Martino et al. [178] and Craddock et al. [191] performed the feature selection process using a wrapper method, recursive feature elimination. Zeng et al. [51] used the Kendall tau rank correlation coefficient in order to evaluate the power of the feature.
Although feature extraction and selection have considerable impact on the success or failure of the classification process, it is clear that there is still a lack of proper feature extraction and selection investigation for depression. Thus, future works should attempt to find the most discriminant features for individual/single-subject classification of depression.
Classification
As previously described, limited studies have been conducted involving distinct classifiers for the detection of depression from sMRI. From Table 2 , the most popular classifier used in the sMRI-based depression studies is the SVM classifier. Four of the studies utilized the SVM classifier [70, 107, 109, 111] ; Nouretdinov et al. utilized the TCP classifier [108] , while Mwangi et al. [70, 110] investigated RVM as classifier.
SVM is also a very popular classifier in other brain imaging disease classification studies (i.e., Alzheimer's disease, autism, brain maturity [52, 192, 193] ). In depression classification by fMRI, Fu et al. [63] , Marquand et al. [189] , and Zeng et al. [51] also employed the SVM classifier. Hahn et al. [62] proposed a hybrid classifier algorithm based on the GP and the decision tree classifier algorithms for the detection of depression. There are many other existing classification methods that can be applied to depression detection. Other classification methods commonly used include k-nearest neighbor [187] , artificial neural network [187] , and unsupervised c means clustering [194] .
Conclusions
This paper presented an overview of the existing sMRIbased depression detection methods. Also, based on the existing published works, a generic structure of depression detection from sMRI scans was proposed. The algorithms used to realize various components of the existing systems were described and the bottleneck in comparing the published works was highlighted. Lastly, the paper also categorized the existing reported works in depression detection into (1) group-level analysis and (2) individual detection.
The development of the sMRI-based depression detection systems is still at its infancy with only few studies published. However, the research to date already highlights the potential of sMRI-based analysis for the diagnosis and prognosis of depression. Future research should focus on the collection and utilization of larger databases and careful characterization of the impact of features that influence the performance of the classifiers. In addition, further evaluation of different methods for feature extraction, feature selection, and feature classification are vital to the successful and reliable implementation of automated depression detection systems.
